EU-VAP/CAP Study
Pneumonia in Patients requiring mechanical ventilation in European Intensive Care Units

Lead Investigator: Jordi Rello

The scientific literature is plenty of articles about the diagnosis and treatment of pneumonia in the ICU. However, the information concerning both the actual clinical practice and the reason for the implementation of such a practice is limited.
The EU-VAP/CAP is the first prospective, observational study that is specifically designed to look at the clinical management of pneumonia in the European ICUs (27 participating ICUs from 9 European countries: Belgium, France, Germany, Greece, Italy, Ireland, Portugal, Spain, Turkey). The aim of the study is to provide insight on the current status of CAP/HAP/VAP diagnosis, pathogenic organisms, and therapies in European ICUs, as well as the utilization of this information as a tool in the effort to improve outcomes. More than 2500 patients have been recruited in the study and the interpretation of the collected data is ongoing.
EU-VAP/CAP Study is a project of the Working Group on Pneumonia (Head: Jordi Rello) of the Infection Section of the European Society of Intensive Care Medicine (ESICM) and it has been endorsed by European Critical Care Research Network (ECCRN)

For further information you may contact:
Prof. Jordi Rello (principal investigator) or
Dr Despoina Koulenti (study coordinator)

EUVAP-CAP / STUDY on Facebook

Comments are closed